The Efficacy and Prognostic Factors of the Combination of TACE and Apatinib for the Treatment of BCLC Stage C Hepatocellular Carcinoma

Objective: Apatinib is a inhibitor of vascular endothelial growth factor receptor-2. To explore the efficacy and prognostic factors of transarterial chemoembolization (TACE) combined with apatinib in the treatment of Barcelona Clinic Liver Cancer stage C (BCLC C) hepatocellular carcinoma (HCC). Meth...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Shun, Liu, Kai-Cai, Lv, Wei-Fu, Lu, Dong, Zhu, Xian-Hai, Jiang, Bo, Tan, Yu-Lin, Wang, Guo-Xiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8713136/
https://www.ncbi.nlm.nih.gov/pubmed/34970563
http://dx.doi.org/10.3389/fmed.2021.774345

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8713136/
https://www.ncbi.nlm.nih.gov/pubmed/34970563
http://dx.doi.org/10.3389/fmed.2021.774345

Ejemplares similares